CHRNA1 antibody (AA 105-220)
Quick Overview for CHRNA1 antibody (AA 105-220) (ABIN6138570)
Target
See all CHRNA1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 105-220
-
Sequence
- IWRPDLVLYN NADGDFAIVK FTKVLLQYTG HITWTPPAIF KSYCEIIVTH FPFDEQNCSM KLGTWTYDGS VVAINPESDQ PDLSNFMESG EWVIKESRGW KHSVTYSCCP DTPYLD
-
Cross-Reactivity
- Human, Mouse
-
Characteristics
- Polyclonal Antibodies
-
Purification
- Affinity purification
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 105-220 of human CHRNA1 (NP_000070.1).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:500 - 1:2000
-
Comment
-
HIGH QUALITY
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- CHRNA1 (Acetylcholine Receptor Subunit alpha (CHRNA1))
-
Alternative Name
- CHRNA1
-
Background
- The muscle acetylcholine receptor consiststs of 5 subunits of 4 different types: 2 alpha subunits and 1 each of the beta, gamma, and delta subunits. This gene encodes an alpha subunit that plays a role in acetlycholine binding/channel gating. Alternatively spliced transcript variants encoding different isoforms have been identified.,CHRNA1,ACHRA,ACHRD,CHRNA,CMS1A,CMS1B,CMS2A,FCCMS,SCCMS,Neuroscience,Neurodegenerative Diseases,Amyloid Plaque and Neurofibrillary Tangle Formation in Alzheimer's Disease,CHRNA1
-
Molecular Weight
- 51 kDa/54 kDa
-
Gene ID
- 1134
-
UniProt
- P02708
-
Pathways
- Skeletal Muscle Fiber Development
Target
-